Next, immunohistochemistry (IHC), qRT-PCR and western blotting were performed to further verify that CDCA3 was highly expressed in RCC tissues at both the mRNA and protein levels (Fig. 4f, g). Here, CDCA3 is linked to renal cell carcinoma.